Biomarkers for kidney cancer

Large-scale genomic analysis of renal cell carcinoma combined with clinical and epidemiological information would address the need for disease molecular markers. This could potentially lead to new diagnostic tools and the design of targeted treatments.

The incidence of renal cell carcinoma has been increasing in Europe over the past two decades. In certain parts of Europe the disease is particularly prevelant and it therefore presents serious health concerns in these areas.

The principal objective of the EU-funded 'Cancer genomics of the kidney' (Cagekid) project is to obtain a comprehensive understanding of genetic and epigenetic changes that occur in the most common form of renal cancer, clear cell renal cell carcinoma (ccRCC). The project is part of the International Cancer Genome Consortium (ICGC), whose goal is to obtain genomic analyses of the 50 most common cancer types.

More details can be found at the following link: http://cordis.europa.eu/fetch?CALLER=OFFR_TM_EN&ACTION=D&RCN=10920